Work with thought leaders and academic experts in Immunology

Companies can greatly benefit from working with experts in the field of Immunology. These researchers can provide valuable insights and expertise to enhance research and development efforts. They can help in the development of new drugs and therapies, conduct preclinical and clinical trials, and provide guidance on regulatory compliance. Additionally, Immunology experts can contribute to the understanding of disease mechanisms, identify potential biomarkers, and develop diagnostic tools. Their knowledge can also be applied in the fields of personalized medicine, immunotherapy, and vaccine development. Collaborating with Immunology researchers can lead to breakthrough discoveries, improved patient outcomes, and a competitive advantage in the healthcare industry.

Researchers on NotedSource with backgrounds in Immunology include Boris Leibovitch, Michael W Harman, Ping Luo, Regan Hamel, Mohammad Imran Khan, Elvira Forte, Dr. David Siderovski, Ph.D., Susan Song, MD/PhD, Shariq Usmani, PhD, Odion Ikhimiukor, Theresa Higgins, Dr. Lindsey Kuehm, Ph.D., Joseph Bucukovski, Ph.D., Brendan Monogue, Ph.D., Jeffrey Townsend, Katie Barr, Dr. Justin Whalley, Ph.D, Rosani Matoso Silva, Ph.D., Lindsay Webb, PhD, Sai Pranathi Meda Venkata, Roberto M. Alers Velazquez, Ph.D., Giuliana Noratto, Adrienne Lucas, Tensie Whelan, and Liam D. Hendrikse, Ph.D..

Boris Leibovitch

New York, New York, United States of America
30 Years Experience
Experienced wet lab and in teaching Molecular Cell biologist, geneticist, cancer biologist in Academia
Education

Moscow Region State University

PhD, Molecular Biology / April, 1978

Moscow

Moscow Region State University

MS, Genetics / July, 1972

Moscow

Moscow Region State University

BS, Genetics / April, 1971

Moscow
Experience

NYU Langone Medical Center

Associate Research Scientist / June, 2021 — September, 2022

Wet lab research and teaching Molecular and Cell Biology in MD program

Icahn School of Medicine at Mount Sinai

Assistant Professor / July, 2004 — June, 2021

Wet lab research and teaching Molecular and Cell Biology in MD program

Washington University in St. Louis

Post-doctoral Research Associate / June, 1994 — June, 2004

Wet lab research and teaching Molecular and Cell Biology in MS program

Most Relevant Research Expertise
Immunology
Other Research Expertise (8)
Cancer Research
Cell Biology
Developmental Biology
Molecular Biology
Hematology
And 3 more
About
I am experienced molecular and cell biologist with deep genetics background who worked many years in USA and Russia on the bench and as teacher. Both types of work had demanded extremely broad knowledge and understanding of developments in the fields. Participation in grant writing, editorial/reviewer work for scientific journals and consulting colleagues on these subjects added a lot to my broad experience as the scientist.
Most Relevant Publications (1+)

22 total publications

The MMSET protein is a histone methyltransferase with characteristics of a transcriptional corepressor

Blood / Mar 15, 2008

Marango, J., Shimoyama, M., Nishio, H., Meyer, J. A., Min, D.-J., Sirulnik, A., Martinez-Martinez, Y., Chesi, M., Bergsagel, P. L., Zhou, M.-M., Waxman, S., Leibovitch, B. A., Walsh, M. J., & Licht, J. D. (2008). The MMSET protein is a histone methyltransferase with characteristics of a transcriptional corepressor. Blood, 111(6), 3145–3154. https://doi.org/10.1182/blood-2007-06-092122

See Full Profile

Michael W Harman

East Greenwich, RI, Rhode Island, United States of America
7 Years Experience
Distinguished Subject Matter Expert & Leader in Medical Technologies.
Education

University of Connecticut

BS, Biomedical Engineering, Biofluid Mechanics Track / May, 2008

Storrs, Connecticut, United States of America

University of Connecticut

MS, Biomedical Engineering, Biomechanics Concentration / December, 2009

Storrs, Connecticut, United States of America

University of Arizona

Ph.D, Biochemistry, Molecular and Cellular Biology / December, 2015

Tucson, Arizona, United States of America
Experience

Brown University

Postdoctoral Research Fellow / May, 2016 — August, 2018

Critical lead asset driving preclinical collaborative cell biomechanics study managing 30 personnel between immunology, pathobiology, and experimental soft matter mechanics laboratories.

Rhode Island Hospital

Postdoctoral Research Fellow / May, 2016 — August, 2018

Critical lead asset driving preclinical collaborative cell biomechanics study managing 30 personnel between immunology, pathobiology, and experimental soft matter mechanics laboratories.

Ximedica

Research & Development Engineer / September, 2018 — October, 2019

Provided technical subject matter expertise to enhance the clinical performance of novel medical products being designed.

Research & Development Engineering Manager / October, 2019 — July, 2020

Grew a team of Research & Development Engineers out of our traditional designer, mechanical, and electrical engineering departments to form a novel team within the organization and supported each of their individual professional development needs.

Most Relevant Research Expertise
Immunology
Other Research Expertise (13)
Bacteria & Cell Bio-Physics
Biomechanics
Infectious Diseases
Microbiology
Parasitology
And 8 more
About
Highly skilled, energetic, and motivated professional empowered by over a decade of cross-disciplinary engineering and scientific applications experience. Presenting elegant solutions to prevalent biomedical challenges. Motivated by driving deliverable outcomes from complex research studies through effective leadership, active consulting work, and innovative problem-solving techniques. Seeking to make an immediate impact in a fast-paced biotechnology environment capitalizing on my advanced comprehension, continued professional growth, strategic product development expertise, and active network of personal connections across all areas of science, engineering, medicine, manufacturing and healthcare.
Most Relevant Publications (1+)

15 total publications

The Hybrid Histidine Kinase Hk1 Is Part of a Two-Component System That Is Essential for Survival of Borrelia burgdorferi in Feeding Ixodes scapularis Ticks

Infection and Immunity / Aug 01, 2011

Caimano, M. J., Kenedy, M. R., Kairu, T., Desrosiers, D. C., Harman, M., Dunham-Ems, S., Akins, D. R., Pal, U., & Radolf, J. D. (2011). The Hybrid Histidine Kinase Hk1 Is Part of a Two-Component System That Is Essential for Survival of Borrelia burgdorferi in Feeding Ixodes scapularis Ticks. Infection and Immunity, 79(8), 3117–3130. https://doi.org/10.1128/iai.05136-11

See Full Profile

Ping Luo

Toronto, Ontario, Canada
8 Years Experience
Assistant Professor at Algoma University
Education

University of Saskatchewan

Ph.D., Biomedical Engineering / September, 2019

Saskatoon, Saskatchewan, Canada

Beijing Institute of Technology

M.Eng., Biomedical Engineering / June, 2015

Beijing

Hunan University

B.Eng., Computer Science / June, 2010

Changsha
Experience

Princess Margaret Cancer Centre

Postdoctoral Researcher / November, 2019 — Present

I work in Dr. Trevor Pugh's lab and design cancer diagnosis and treatment strategies by analyze cell-free DNA and single cell sequencing data

Princess Margaret Cancer Centre

Bioinformatics Specialist / September, 2023 — Present

I work in Dr. Tak Mak's lab and study tumor immunology using single cell and TCR sequencing data.

Most Relevant Research Expertise
Immunology
Other Research Expertise (21)
single-cell genomics
deep learning
complex network analysis
Genetics (clinical)
Genetics
And 16 more
About
8 years of science and engineering experience integrating multi-omics data to identify biomarkers for cancer studies. Seeking to apply data analytics expertise to develop new diagnosis and treatment strategies.
Most Relevant Publications (1+)

23 total publications

Normalization of the Immune Microenvironment during Lenalidomide Maintenance Is Associated with Sustained MRD Negativity in Patients with Multiple Myeloma

Blood / Nov 05, 2021

Coffey, D. G., Maura, F., Gonzalez-Kozlova, E., Diaz-Mejia3, J., Luo, P., Zhang, Y., Xu, Y., Warren, E. H., Smith, E. L., Cho, H. J., Lesokhin, A., Diamond, B., Kazandjian, D., Pugh, T. J., Green, D. J., Gnjatic, S., & Landgren, O. (2021). Normalization of the Immune Microenvironment during Lenalidomide Maintenance Is Associated with Sustained MRD Negativity in Patients with Multiple Myeloma. Blood, 138(Supplement 1), 329–329. https://doi.org/10.1182/blood-2021-154506

See Full Profile

Regan Hamel

Cambridge
6 Years Experience
Senior bioinformatics scientist, specializing in single cell omics in the context of cellular reprogramming and neuroinflammation
Education

University of Cambridge

PhD, Clinical Neurosciences / September, 2021

Cambridge

University of Cambridge

MPhil, Clinical Neurosciences / September, 2018

Cambridge

McGill University

Bachelor of Science, Neurosciences / June, 2017

Montreal
Experience

Mogrify Ltd

Bioinformatics scientist / August, 2021 — June, 2023

Senior Bioinformatics Scientist / July, 2023 — Present

Most Relevant Research Expertise
Immunology
Other Research Expertise (12)
single cell biology
transcriptomics
Cellular and Molecular Neuroscience
Cell Biology
Developmental Biology
And 7 more
About
Regan Hamel has an MPhil and PhD in Clinical Neurosciences from University of Cambridge. She also has a Bachelor of Science in Neurosciences from McGill University. Her PhD with Stefano Pluchino and John Marioni focused on single cell transcriptomics in the context of neuroinflammation. Since 2021 she has worked as a Bioinformatics scientist at Mogrify Ltd, applying a multitude of computational biology techniques (including single cell omics, bulk RNAseq, and predictive modelling) in the context of cell reprogramming
Most Relevant Publications (2+)

12 total publications

Metabolic Control of Smoldering Neuroinflammation

Frontiers in Immunology / Jun 23, 2021

Peruzzotti-Jametti, L., Willis, C. M., Hamel, R., Krzak, G., & Pluchino, S. (2021). Metabolic Control of Smoldering Neuroinflammation. Frontiers in Immunology, 12. https://doi.org/10.3389/fimmu.2021.705920

Bioinformatics analysis identified apolipoprotein E as a hub gene regulating neuroinflammation in macrophages and microglia following spinal cord injury

Frontiers in Immunology / Aug 24, 2022

Yao, X.-Q., Chen, J.-Y., Yu, Z.-H., Huang, Z.-C., Hamel, R., Zeng, Y.-Q., Huang, Z.-P., Tu, K.-W., Liu, J.-H., Lu, Y.-M., Zhou, Z.-T., Pluchino, S., Zhu, Q.-A., & Chen, J.-T. (2022). Bioinformatics analysis identified apolipoprotein E as a hub gene regulating neuroinflammation in macrophages and microglia following spinal cord injury. Frontiers in Immunology, 13. https://doi.org/10.3389/fimmu.2022.964138

See Full Profile

Mohammad Imran Khan

College Park, Maryland, United States of America
3 Years Experience
Postdoctoral Associate at University of Maryland College Park in the Department of Nutrition and Food Science
Education

Kalinga Institute of Industrial Technology

PhD, School of Biotechnology / February, 2021

Bhubaneswar

Kalinga Institute of Industrial Technology

M.Sc., Biotechnology / July, 2014

Bhubaneswar
Experience

Columbia University Irving Medical Center, New York

Postdoctoral Research Scientist / August, 2021 — October, 2021

The George Washington University, Washington D.C.

Postdoctoral Associate / May, 2022 — March, 2023

University of Maryland College Park

Postdoctoral Associate / April, 2023 — Present

Most Relevant Research Expertise
Immunology
Other Research Expertise (22)
Biomedical Engineering
Nanotechology
Wound healing
Infection and Immunity
Bioengineering
And 17 more
About
Research work is focused on the formulation of nanoparticles encapsulated materials which could be useful for tissue engineering, stem cells, drug delivery and biomechanics to create biologically inspired tissue and organ constructs. Furthermore, 3D material may play significant role in the healing of complex tissues and organs in vitro and in vivo.
Most Relevant Publications (1+)

11 total publications

Biogenic Au@ZnO core–shell nanocomposites kill Staphylococcus aureus without provoking nuclear damage and cytotoxicity in mouse fibroblasts cells under hyperglycemic condition with enhanced wound healing proficiency

Medical Microbiology and Immunology / Oct 05, 2018

Khan, Md. I., Behera, S. K., Paul, P., Das, B., Suar, M., Jayabalan, R., Fawcett, D., Poinern, G. E. J., Tripathy, S. K., & Mishra, A. (2018). Biogenic Au@ZnO core–shell nanocomposites kill Staphylococcus aureus without provoking nuclear damage and cytotoxicity in mouse fibroblasts cells under hyperglycemic condition with enhanced wound healing proficiency. Medical Microbiology and Immunology, 208(5), 609–629. https://doi.org/10.1007/s00430-018-0564-z

See Full Profile

Elvira Forte

New York, New York, United States of America
15 Years Experience
Scientific strategist • Senior Scientist • Senior Scientific Editor
Education

Sapienza University of Rome

PhD, Pasteurian Sciences / January, 2011

Rome

Sapienza University of Rome

Master, Medical, Molecular and Cellular Biotechnology / October, 2006

Rome

Sapienza University of Rome

Bachelor, Biotechnology / October, 2004

Rome
Experience

Springer Nature

Associate/Senior Editor / June, 2021 — February, 2024

Helped shape and launch a new journal, Nature Cardiovascular Research, which publishes exceptional advances in the fields of cardiac, vascular, and blood biology, covering fundamental, translational, clinical, and public health research. • Assessed the novelty and impact of manuscripts within all the topics covered by the journal and chaperoned the whole revision process until acceptance for over 40% of all the content published by the journal since its start, with optimal processing times and excellent feedback from the authors. • Interfaced with scientists around the World, provided scientific guidance on how to improve manuscripts, or recommended more appropriate journals to publish with. Commissioned Comments, Reviews, News and Views on current topics, and summarized novel scientific findings in meaningful snippets and Research Highlights. • Contributed to the training and supervision of 2 Associate Editors; covered the Chief Editor's functions when needed.

Research Fellow/Associate Research Scientist / January, 2017 — June, 2021

• Analyzed the dynamic cellular changes during the fibrotic repair post-myocardial infarction, using cutting-edge techniques such as single-cell RNAseq with 10xChromium. Learned how to perform myocardial infarction in mice and assess the cardiac function via echography; analyze scRNAseq data using the Seurat package on R studio. • Completed a project aimed to characterize similarities and differences among fibroblasts from different organs cultured in the same conditions. Through cytometric, transcriptomic analysis, functional assays, shRNA and CRISPR-Cas9-mediated in vitro gene knockdowns we showed that fibroblasts isolated from different organs retain the expression of key transcription factors reflecting their embryological origin. • Collaborated with other laboratories in the Institute to design new mice models that could possibly recapitulate the symptoms of COVID-19; to analyze the response of mice with diverse genetic backgrounds to stressors.

Post-doctoral fellow/ Co-joint lecturer / May, 2013 — November, 2016

Developed projects aimed at understanding the embryological origin and function of a population of putative progenitor cells, cardiac colony forming unit fibroblasts cCFU-F, identified 2 years before in the lab (PMID: 22136928). • Performed cell lineage tracing and designed in vitro and in vivo cellular assays to assess the functional and immunomodulatory properties of PDGFRa+ fibroblasts in homeostasis and post-myocardial infarction with or without treatment with the PDGF-AB ligands. The data, presented in 3 international conferences and included in a preprint manuscript, have supported the use of a short-term treatment with PDGF-AB in a preclinical model of acute myocardial infarction in pigs. • Co-supervised 2 Ph.D. students at University of New South Wales

Scientific Editor / March, 2024 — Present

Consultant freelancer position within a team of former journal editors and grants specialists • Helped scientists increase the impact of their science by providing advice, in-depth editing, and feedback on manuscripts.

Most Relevant Research Expertise
Immunology
Other Research Expertise (26)
fibrosis
inflammation
cardiomyopathies
Physiology
Cardiology and Cardiovascular Medicine
And 21 more
About
Motivated and growth-driven biomedical scientist with over 15 years of experience in the cardiovascular field. Strong background in cell and molecular biology, data analysis, and interpretation. Seeking #newopportunities to deliver value as a Senior Scientist, Associate Principal Scientist, Scientific Liaison, or Scientific Consultant within a company that combines new technologies such as single-cell omics and AI for drug discovery and personalized medicine. <br> Throughout my career, I've used various in vivo and in vitro models to investigate the molecular and cellular mechanisms of fibrosis and inflammation in the heart, and how these mechanisms are affected in mice with different genetic backgrounds. My experience includes project management and mentoring. I completed three projects involving international collaborations, supervised two junior researchers, and taught cellular and molecular techniques to at least six professionals. As one of the launching editors and senior editor at Nature Cardiovascular Research, I oversaw the quality of the content published in the journal and the editorial process. I collaborated with authors, reviewers, and editors to ensure the highest standards of scientific rigor, relevance, and innovation. I also contributed to the journal's vision, strategy, and outreach, promoting the latest advances and discoveries in the cardiovascular and hematology fields. This experience has sharpened my analytical and communication skills and broadened my understanding of the field, covering a wide range of studies, from basic research to clinical, epidemiological, and public health research. My mission is to advance the knowledge and practice of cardiovascular medicine and to bridge the gap between research and clinical applications. Keywords: cardiovascular, #fibrosis, inflammation, cardioimmunology, RNA, single-cell biology, #transcriptomics, imaging, animal models, small animal surgery, and scientific writing.
Most Relevant Publications (2+)

63 total publications

HLA-DQ8 Supports Development of Insulitis Mediated by Insulin-Reactive Human TCR-Transgenic T Cells in Nonobese Diabetic Mice

The Journal of Immunology / Dec 15, 2023

Racine, J. J., Misherghi, A., Dwyer, J. R., Maser, R., Forte, E., Bedard, O., Sattler, S., Pugliese, A., Landry, L., Elso, C., Nakayama, M., Mannering, S., Rosenthal, N., & Serreze, D. V. (2023). HLA-DQ8 Supports Development of Insulitis Mediated by Insulin-Reactive Human TCR-Transgenic T Cells in Nonobese Diabetic Mice. The Journal of Immunology, 211(12), 1792–1805. https://doi.org/10.4049/jimmunol.2300303

Murine MHC-Deficient Nonobese Diabetic Mice Carrying Human HLA-DQ8 Develop Severe Myocarditis and Myositis in Response to Anti–PD-1 Immune Checkpoint Inhibitor Cancer Therapy

The Journal of Immunology / Mar 01, 2024

Racine, J. J., Bachman, J. F., Zhang, J.-G., Misherghi, A., Khadour, R., Kaisar, S., Bedard, O., Jenkins, C., Abbott, A., Forte, E., Rainer, P., Rosenthal, N., Sattler, S., & Serreze, D. V. (2024). Murine MHC-Deficient Nonobese Diabetic Mice Carrying Human HLA-DQ8 Develop Severe Myocarditis and Myositis in Response to Anti–PD-1 Immune Checkpoint Inhibitor Cancer Therapy. The Journal of Immunology, 212(8), 1287–1306. https://doi.org/10.4049/jimmunol.2300841

See Full Profile

Dr. David Siderovski, Ph.D.

Fort Worth
25 Years Experience
Professor of Computational Pharmacology; Chair of HSC SBS Dept. of Pharmacology & Neuroscience
Education

University of Toronto

Ph.D., Medical Biophysics / November, 1997

Toronto, Ontario, Canada
Experience

University of North Carolina at Chapel Hill

Professor / January, 1999 — June, 2012

West Virginia University School of Medicine

E.J. Van Liere Endowed Medicine Professor and Chairman / July, 2012 — February, 2020

Chair of the Dept. of Physiology and Pharmacology

University of North Texas Health Science Center

Professor & Chair / March, 2020 — Present

Most Relevant Research Expertise
Immunology
Other Research Expertise (25)
Regulator of G protein Signaling (RGS) proteins
Pharmacology
Molecular Biology
Cellular and Molecular Neuroscience
Molecular Medicine
And 20 more
About
Dr. David Siderovski is a renowned scientist and academic, with a career spanning over two decades. He received his Ph.D. in Medical Biophysics from the University of Toronto in 1997, where he specialized in signal transduction and cellular signaling pathways. After completing his doctorate, Dr. Siderovski held various faculty positions at prestigious universities, including the University of North Carolina at Chapel Hill, West Virginia University School of Medicine, and the University of North Texas Health Science Center. At these institutions, Dr. Siderovski has made significant contributions to the field of pharmacology through his research on G protein-coupled receptors (GPCRs) and RGS proteins, which are key regulators of GPCR cellular signaling. His work has helped to advance the understanding of RGS proteins and their roles in various diseases, including cancer, cardiovascular disorders, and neurological disorders. In addition to his research, Dr. Siderovski is also a dedicated educator and mentor. He has taught and mentored numerous undergraduate, graduate, and medical students, and has served as a mentor for postdoctoral fellows and junior faculty members. He is known for his passion and enthusiasm for science and his ability to inspire and guide the next generation of scientists. Dr. Siderovski has received numerous awards and honors for his contributions to the scientific community. He was the recipient of the Abel Award in 2004 from the American Society of Pharmacology & Experimental Therapeutics for his pioneering discoveries of the RGS proteins and the GoLoco motif. He has also served on editorial boards of several scientific journals (including a decade at *J.Biol.Chem.*) and has been a member of various scientific committees, NIH study section panels, and pharma/biotech advisory boards, including for Inspire, Wyeth, and BellBrook Labs. Overall, Dr. David Siderovski is a highly accomplished and respected scientist and educator, whose research has had a significant impact on the field of pharmacology. His dedication and passion for science continue to inspire and influence the next generation of researchers in this field.
Most Relevant Publications (2+)

94 total publications

The Mitochondrial Proteins NLRX1 and TUFM Form a Complex that Regulates Type I Interferon and Autophagy

Immunity / Jun 01, 2012

Lei, Y., Wen, H., Yu, Y., Taxman, D. J., Zhang, L., Widman, D. G., Swanson, K. V., Wen, K.-W., Damania, B., Moore, C. B., Giguère, P. M., Siderovski, D. P., Hiscott, J., Razani, B., Semenkovich, C. F., Chen, X., & Ting, J. P.-Y. (2012). The Mitochondrial Proteins NLRX1 and TUFM Form a Complex that Regulates Type I Interferon and Autophagy. Immunity, 36(6), 933–946. https://doi.org/10.1016/j.immuni.2012.03.025

A P-loop Mutation in Gα Subunits Prevents Transition to the Active State: Implications for G-protein Signaling in Fungal Pathogenesis

PLoS Pathogens / Feb 23, 2012

Bosch, D. E., Willard, F. S., Ramanujam, R., Kimple, A. J., Willard, M. D., Naqvi, N. I., & Siderovski, D. P. (2012). A P-loop Mutation in Gα Subunits Prevents Transition to the Active State: Implications for G-protein Signaling in Fungal Pathogenesis. PLoS Pathogens, 8(2), e1002553. https://doi.org/10.1371/journal.ppat.1002553

See Full Profile

Susan Song, MD/PhD

Pittsburgh, Pennsylvania, United States of America
9 Years Experience
Research Assistant Professor in Neuroscience at University of Pittsburgh
Education

Southern Medical University

MD/PhD, Neurology, Neuroscience / June, 2015

Guangzhou

University of Pittsburgh

Post-doc, Neuroscience / December, 2019

Pittsburgh, Pennsylvania, United States of America
Experience

University of Pittsburgh

Research Assistant Professor / January, 2022 — Present

Research Instructor / January, 2020 — December, 2021

Postdoctoral Scholar / October, 2015 — December, 2019

Most Relevant Research Expertise
Immunology
Other Research Expertise (15)
microglia
white matter
neurodegenerative disease
Cellular and Molecular Neuroscience
Neurology
And 10 more
About
Susan Song, MD/PhD, is a highly accomplished neuroscientist, with extensive education and experience in the field. She received her MD/PhD in Neurology and Neuroscience from Southern Medical University in 2015, where she conducted groundbreaking research on the molecular mechanisms of neurodegenerative diseases. Following this, she completed a post-doctoral fellowship in Neuroscience at the University of Pittsburgh, where she continued to excel in her research and received numerous awards and grants for her work. Dr. Song's expertise lies in studying the underlying causes and potential treatments for various neurological diseases, such as ischemic stroke, traumatic brain injury, glioblastoma, Alzheimer's disease, and multiple sclerosis. She has a deep understanding of the brain and nervous system, and is constantly seeking new ways to unravel the complexities of these diseases. Dr. Song has held several prestigious positions throughout her career, including her current position as Research Assistant Professor at the University of Pittsburgh. She has published numerous articles in top scientific journals and presented her research at international conferences. Her findings have contributed greatly to the field of neurology and have the potential to improve the lives of millions of people suffering from neurological disorders. Overall, Dr. Song is a highly respected and accomplished physician-scientist who is making significant contributions to the field of neurology. With her extensive education, diverse experience, and unwavering dedication to her patients, she is a true leader in the field and a valuable asset to the medical community.
Most Relevant Publications (2+)

20 total publications

Attenuating vascular stenosis-induced astrogliosis preserves white matter integrity and cognitive function

Journal of Neuroinflammation / Aug 28, 2021

Liu, Q., Bhuiyan, M. I. H., Liu, R., Song, S., Begum, G., Young, C. B., Foley, L. M., Chen, F., Hitchens, T. K., Cao, G., Chattopadhyay, A., He, L., & Sun, D. (2021). Attenuating vascular stenosis-induced astrogliosis preserves white matter integrity and cognitive function. Journal of Neuroinflammation, 18(1). https://doi.org/10.1186/s12974-021-02234-8

Microglial–oligodendrocyte interactions in myelination and neurological function recovery after traumatic brain injury

Journal of Neuroinflammation / Oct 05, 2022

Song, S., Hasan, M. N., Yu, L., Paruchuri, S. S., Bielanin, J. P., Metwally, S., Oft, H. C. M., Fischer, S. G., Fiesler, V. M., Sen, T., Gupta, R. K., Foley, L. M., Hitchens, T. K., Dixon, C. E., Cambi, F., Sen, N., & Sun, D. (2022). Microglial–oligodendrocyte interactions in myelination and neurological function recovery after traumatic brain injury. Journal of Neuroinflammation, 19(1). https://doi.org/10.1186/s12974-022-02608-6

See Full Profile

Shariq Usmani, PhD

Boston, Massachusetts, United States of America
15 Years Experience
Massachusetts General Hospital, Harvard Medical School
Education

University of Konstanz

PhD, Molecular and Cell Biology / May, 2011

Konstanz

Harvard University

Postdoctoral fellow, Virology/Immunology / 2019

Cambridge, Massachusetts, United States of America
Experience

Cabaletta Bio

Scientific Director / 2024 — Present

I lead a research team in the preclinical R&D organization at Cabaletta bio. I directly manage a talented group of Senior Scientists, Scientists and Research Associates to spearhead and drive innovation in cell therapies and biologics in autoimmune disease indications.

Sana Biotechnology

Principal Scientist / 2022 — 2023

As a team lead, I led efforts to establish in vivo genome editing platform, vector design/engineering and optimization, with a broader goal to develop innovative and effective genomic medicine for unmet medical needs.

Zohdan Bio

Consultant / 2024 — Present

Providing strategic support for all aspects of preclinical, R&D programs in gene therapy, genome editing and virology and immunology space.

Most Relevant Research Expertise
Immunology
Other Research Expertise (9)
Microbiology
Virology
Molecular Biology
Genetics
Biochemistry
And 4 more
About
Dr. Shariq Usmani is scientific director at Cabaletta bio, a leader in cell therapy for autoimmune diseases (https://www.cabalettabio.com). He leads a research team in preclinical R&D organization at Cabaletta bio. He directly manage a talented group of Senior Scientists, Scientists and Research Associates to spearhead and drive innovation in cell therapies and biologics in autoimmune disease indications. <br> He is also serves as consultant at Zohdan Bio, where he provides strategic support for preclinical R&D programs focused on gene therapy, genome editing, and virology. With a deep foundation in oncology and biologics, Dr. Usmani has led groundbreaking work in both academia and industry, including his tenures at Sana Biotechnology, Harvard Medical School and Massachusetts General Hospital. He's led and spearheaded the development of innovative in vivo genome editing platforms, optimized viral vectors, and engineered cutting-edge reporter assays.
Most Relevant Publications (7+)

22 total publications

Human Tetherin Exerts Strong Selection Pressure on the HIV-1 Group N Vpu Protein

PLoS Pathogens / Dec 20, 2012

Sauter, D., Unterweger, D., Vogl, M., Usmani, S. M., Heigele, A., Kluge, S. F., Hermkes, E., Moll, M., Barker, E., Peeters, M., Learn, G. H., Bibollet-Ruche, F., Fritz, J. V., Fackler, O. T., Hahn, B. H., & Kirchhoff, F. (2012). Human Tetherin Exerts Strong Selection Pressure on the HIV-1 Group N Vpu Protein. PLoS Pathogens, 8(12), e1003093. https://doi.org/10.1371/journal.ppat.1003093

Liquefaction of Semen Generates and Later Degrades a Conserved Semenogelin Peptide That Enhances HIV Infection

Journal of Virology / Jul 01, 2014

Roan, N. R., Liu, H., Usmani, S. M., Neidleman, J., Müller, J. A., Avila-Herrera, A., Gawanbacht, A., Zirafi, O., Chu, S., Dong, M., Kumar, S. T., Smith, J. F., Pollard, K. S., Fändrich, M., Kirchhoff, F., Münch, J., Witkowska, H. E., & Greene, W. C. (2014). Liquefaction of Semen Generates and Later Degrades a Conserved Semenogelin Peptide That Enhances HIV Infection. Journal of Virology, 88(13), 7221–7234. https://doi.org/10.1128/jvi.00269-14

Efficient Nef-Mediated Downmodulation of TCR-CD3 and CD28 Is Associated with High CD4 + T Cell Counts in Viremic HIV-2 Infection

Journal of Virology / May 01, 2012

Khalid, M., Yu, H., Sauter, D., Usmani, S. M., Schmokel, J., Feldman, J., Gruters, R. A., van der Ende, M. E., Geyer, M., Rowland-Jones, S., Osterhaus, A. D., & Kirchhoff, F. (2012). Efficient Nef-Mediated Downmodulation of TCR-CD3 and CD28 Is Associated with High CD4 + T Cell Counts in Viremic HIV-2 Infection. Journal of Virology, 86(9), 4906–4920. https://doi.org/10.1128/jvi.06856-11

Molecular basis of early epithelial response to streptococcal exotoxin: role of STIM1 and Orai1 proteins

Cellular Microbiology / Dec 13, 2011

Usmani, S. M., von Einem, J., Frick, M., Miklavc, P., Mayenburg, M., Husmann, M., Dietl, P., & Wittekindt, O. H. (2011). Molecular basis of early epithelial response to streptococcal exotoxin: role of STIM1 and Orai1 proteins: Streptolysin O activates SOC entry. Cellular Microbiology, 14(3), 299–315. https://doi.org/10.1111/j.1462-5822.2011.01724.x

Lentiviral Nef Proteins Manipulate T Cells in a Subset-Specific Manner

Journal of Virology / Feb 15, 2015

Yu, H., Khalid, M., Heigele, A., Schmökel, J., M. Usmani, S., van der Merwe, J., Münch, J., Silvestri, G., & Kirchhoff, F. (2015). Lentiviral Nef Proteins Manipulate T Cells in a Subset-Specific Manner. Journal of Virology, 89(4), 1986–2001. https://doi.org/10.1128/jvi.03104-14

Cancer cells relax and resist cytotoxic attack

Immunity / May 01, 2021

Usmani, S. M., & Mempel, T. R. (2021). Cancer cells relax and resist cytotoxic attack. Immunity, 54(5), 853–855. https://doi.org/10.1016/j.immuni.2021.04.017

HIV-enhancing Amyloids Are Prevalent in Fresh Semen and Are a Determinant for Semen's Ability to Enhance HIV Infection: Relevance for HIV Transmission

AIDS Research and Human Retroviruses / Oct 01, 2014

Usmani, S., Liu, H., Pilcher, C. D., Witkowska, H. E., Kirchhoff, F., Greene, W. C., Münch, J., & Roan, N. R. (2014). HIV-enhancing Amyloids Are Prevalent in Fresh Semen and Are a Determinant for Semen’s Ability to Enhance HIV Infection: Relevance for HIV Transmission. AIDS Research and Human Retroviruses, 30(S1), A183–A184. https://doi.org/10.1089/aid.2014.5392.abstract

See Full Profile

Odion Ikhimiukor

Albany, New York, United States of America
6 Years Experience
Postdoctoral Research Scientist at University at Albany, State University of New York
Education

University of Ibadan

PhD Microbiology, Bacterial genomics, Bioinformatics, Microbiology

Ibadan

University of Ibadan

Master of Science (M. Sc.), Environmental Microbiology / April, 2015

Ibadan

University of Abuja

Bachelor of Science (B.Sc.), Microbiology / March, 2011

Abuja
Experience

University at Albany, State University of New York

Postdoctoral Associate

National Institute for Pharmaceutical Research and Development

FCT Emergency Services, Asokoro District Hospital

Most Relevant Research Expertise
Immunology
Other Research Expertise (23)
Pathogen Genomics
Bioinformatics
Molecular Biology
Epidemiology
Environmental Microbiology
And 18 more
About
A postdoctoral research scientist with over 9 years experience in bacterial genomics, microbiology, bioinformatics and antimicrobial resistance research. I’m seeking a Research Scientist or Epidemiologist role at public health genomics laboratories and I am the perfect fit for these roles because I have the following skills: molecular biology, research & development, strategic planning, project management, documentation, outbreak investigation, and cross-functional collaboration skills. I have leveraged my skills to work in a collaborative team-oriented environment to accomplish project goals related to examining the evolution of antimicrobial resistance as evidenced by over 7 national and international collaborations including the New York State Department of Health. I am also a proactive problem-solver adopting innovative and scientific thinking strategies in molecular biology to fulfill project objectives resulting in scientific discoveries including uncovering 1 novel hotspot for the dissemination of resistance in bacteria. I have gained mentorship expertise in promoting data reproducibility, and innovative research methodology in antimicrobial resistance research as evidenced by mentoring 10 professionals on evolutionary genomics, epidemiological statistics, and antimicrobial stewardship. I have also worked collaboratively with a team to apply pathogen genomics, bioinformatics, and leadership skills as demonstrated by working with over 10 highly collaborative teams including the Africa CDC. In addition, I have the following qualifications: Cross-functional collaborator and experience elucidating methods and frequencies of horizontal gene transfer and antimicrobial resistance spread in bacterial species, as demonstrated by 26 peer-reviewed publications including 1 in Nature Microbiology. Experience in leading and managing project details and tasks as evidenced by over 20 projects in pathogen genomics, epidemiology, antimicrobial resistance surveillance, and global health. Astute communication skills in bacterial epidemiology and antimicrobial resistance research resulting in 20 presentations and 6 travel awards to deliver such presentations, including the Bill and Melinda Gates Foundation. I want to serve an organization that prizes community, collaboration and humility among its employees. I’m excited to be on a team built around impact, innovation and a strong, positive reputation. I know I will thrive at a company where responsibility is valued, as well as self-improvement and time-management. I want to be a part of an organization that infuses growth into their brand, culture and market and who I can help make a difference in the world.
Most Relevant Publications (1+)

27 total publications

A bottom-up view of antimicrobial resistance transmission in developing countries

Nature Microbiology / May 30, 2022

Ikhimiukor, O. O., Odih, E. E., Donado-Godoy, P., & Okeke, I. N. (2022). A bottom-up view of antimicrobial resistance transmission in developing countries. Nature Microbiology, 7(6), 757–765. https://doi.org/10.1038/s41564-022-01124-w

See Full Profile

Theresa Higgins

Auburn
7 Years Experience
Research Assistant II || Doctoral Student in Immunology
Education

University of Wyoming

BS, Zoology and Physiology / May, 2021

Laramie, Wyoming, United States of America

Auburn University

Ph.D, Immunology and Cancer Biology / December, 2026 (anticipated)

Auburn, Alabama, United States of America
Experience

University of Wyoming

Undergraduate Research Fellow / May, 2019 — May, 2021

Independent research project on the relationship between song sparrow behavior, intrinsic traits (age, sex, inbreeding), and survival in an isolated island population.

Undergraduate Research Assistant / October, 2017 — May, 2021

Data input and content artist for Hawaii VINE project on the relationship between seed dispersal of invasive plant species and introduced bird species.

Undergraduate Research Fellow / May, 2019 — May, 2020

Independent project on zebra finch personality and behavior and training AI systems.

Field Technician / May, 2021 — June, 2021

Indigo and Lazuli bunting hybridization project.

Auburn University

Research Assistant I / August, 2021 — January, 2022

Molecular biology oncolytic virus research.

Laboratory Technician III / January, 2022 — January, 2024

Project support for several veterinary clinical research projects including canine IMHA, canine ITP, equine respiratory disease, Babesia parasitology, and feline cardiac responses to trauma.

Research Assistant II / January, 2023 — Present

Immunotherapies for cancer treatment including CAR T, oncolytic virus, and immune checkpoint inhibition.

Most Relevant Research Expertise
immunology
Other Research Expertise (11)
osteosarcoma
cancer
CAR T
oncolytic virus
animal behavior
And 6 more
About
I am a current PhD student and experienced laboratory technician in molecular biology, with a strong background in avian behavior and ecology. My current research is focused on oncolytic virus and CAR T immunotherapies as treatment for osteosarcoma in a canine model. Additionally, I am passionate about scientific communication through interdisciplinary work and the arts.

See Full Profile

Joseph Bucukovski, Ph.D.

Rochester, New York, United States of America
10 Years Experience
Accomplished Biomedical Scientist with expertise in Organ-on-Chip (OoC) platforms and immunoassay development
Education

University of Rochester

Ph.D., Biophysics, Structural, and Computational Biology / August, 2024

Rochester, New York, United States of America

University of Rochester

M.S., Biomedical Engineering / October, 2014

Rochester, New York, United States of America

University of Rochester

B.S., Biomedical Engineering / May, 2012

Rochester, New York, United States of America
Experience

Adarza BioSystems

Research Associate / June, 2015 — September, 2016

Senior Research Associate / September, 2016 — May, 2017

• Developed an autoantigen microarray for assaying Sjogren’s syndrome patient samples (published) • Conducted thorough assay development of antibody microarrays to detect systemic levels of chemokines and cytokines in human serum (> 30-plex) • Wrote and revised SOPs for analytical laboratory equipment operation and maintenance • Transferred assay processes and technical expertise to St. Louis manufacturing site • Performed stability testing of coated microarrays for long-term storage capabilities • Trained and mentored laboratory personnel in cleanroom and BSL-2 environments • User of all microarray fabrication printers, with proven ability to streamline, optimize, and troubleshoot scale-up processes • Developed novel data analysis methods to reduce analysis time, improve normalization techniques, and add automation to assay software package • Attended conference to present marketing poster to KOLs, potential customers, and investors based on product development work

Vaccinex, Inc.

Senior Research Associate / September, 2017 — August, 2019

• Lead Critical Reagent Program to ensure proper storage, stability, and inventory of GLP/GMP assay materials • Executed stability and release testing of Phase II drug candidate using bioanalytical methods and prepared technical QC/QA reports for management • Served as the subject matter expert for offsite CRO audit to ensure accuracy of bioanalytical test methods for clinical trials and relevant protocols / documentation • Optimized ELISA PK and ADA (immunogenicity) assays to be used by CRO for testing clinical samples, i.e. CSF, serum, buffer • Assisted with internal production duties such as DNA isolation from E. coli and large-scale transient transfection of CHO/HEK293 cell lines • Optimized ELISA assays to be used by CRO for testing clinical samples, i.e. CSF, serum, buffer • Researched putative biomarkers of neurodegenerative disease in literature and screened patient samples for prevalence of various cytokines, chemokines, and other proteins using Luminex

University of Rochester Medical Center

Graduate Research Assistant (Doctoral Candidate) / January, 2020 — August, 2024

• Designed microfluidic tissue-chip devices to incorporate human tenocyte-laden hydrogels and interrogate wound healing biology with integrated PhRR sensors for real-time cytokine and chemokine measurements (manuscript in progress) • Followed FDA guidelines in Bioanalytical Method Validation to systematically assess the quality and reliability of photonic sensor-derived bioassay data • Developing pneumococcal capsular polysaccharide photonic biosensors to characterize antibody response against serotypes of invasive disease

Most Relevant Research Expertise
Immunology
Other Research Expertise (5)
Optical Biosensors
Bio-photonics
Organ-on-Chip Models
Microphysiological Systems
Cell & Tissue Engineering
About
Biomedical Research Scientist with 10+ years of proven results. I'm passionate about using technology to improve human health. I thrive in taking on challenging projects both in and out the lab and excel as a scientific communicator. My area(s) of expertise is the development of novel immunoassay methods for clinically relevant targets and Organ-on-Chip models to study disease processes and therapeutic efficacy.

See Full Profile

Brendan Monogue, Ph.D.

Denver, Colorado, United States of America
8 Years Experience
PhD Research Associate in Immunology and Microbiology
Education

University of Denver

BS, Biochemistry / June, 2017

Denver, Colorado, United States of America

University of Colorado Anschutz Medical Campus

Ph.D., Microbiology / January, 2023

Aurora, Colorado, United States of America
Experience

University of Colorado Anschutz Medical Campus

Pre-Doctoral Research Assistant / September, 2017 — January, 2023

Led a research project in the lab of Dr. David Beckham studying the role of alpha-synuclein protein in regulating neuroimmune responses

DZNE Bonn

Postdoctoral Researcher / February, 2023 — August, 2024

Postdoctoral Researcher project studying the role of the mTOR pathway in microglial function

University of Coloraod Anschutz

Research Associate / September, 2024 — Present

Post-doctoral research associate studying the impact of chemokine pathways in regulating central B-cell tolerance and autoimmunity

Most Relevant Research Expertise
Immunology
Other Research Expertise (12)
Neurodegeneration
Neuroimmunity
Innate Immunity
Virology
Flow Cytometry
And 7 more
About
I am an experienced researcher with expertise in the fields of immunology, virology, and neuroscience. After developing a background in biochemistry during my undergraduate studies, I pursued my Ph.D. at the University of Colorado Anschutz. My thesis work, focusing on the role of the Parkinson's protein (alpha-synuclein) on immune responses in the central nervous system, helped me develop my skills in assay design, murine modeling, and data analysis. I am particularly skilled at fluorescent microscopy and disease modeling. My work not only resulted in my thesis publication in the journal *Brain,* but also resulted in the successful funding of an R01 grant for our lab. Following this, I developed my molecular biology skills during a brief postdoctoral position in Bonn, Germany. My work in Bonn included pathway analysis and multi-omics analysis. More recently, I have joined the lab of Dr. Roberta Pelanda at the Univeristy of Colorado, studying the origins of autoimmunity and disruptions in central tolerance. I have mentored several students, succesfully applied for grants, and published several peer-reviewed papers.

See Full Profile

Jeffrey Townsend

New Haven, CT, Connecticut, United States of America
29 Years Experience
Professor of Biostatistics and Ecology & Evolutionary Biology
Education

Harvard University

Ph.D., Organismic and Evolutionary Biology / May, 2002

Cambridge, Massachusetts, United States of America

Brown University

Sc.B., Biology / May, 1994

Providence, Rhode Island, United States of America
Experience

Yale University

Professor / July, 2018 — Present

Elihu Professor of Biostatistics / July, 2018 — Present

Elihu Associate Professor of Biostatistics / July, 2017 — June, 2018

Associate Professor / July, 2013 — June, 2018

Associate Professor / July, 2013 — June, 2017

Assistant Professor / July, 2006 — June, 2013

University of Connecticut

Assistant Professor / August, 2004 — May, 2006

St. Ann's School

Teacher / September, 1994 — June, 1997

Most Relevant Research Expertise
Immunology
Other Research Expertise (52)
Evolutionary Genomics
Microbiology
Infectious Diseases
Genetics
Cell Biology
And 47 more
About
Jeffrey Townsend is a Professor of Organismic and Evolutionary Biology at Yale University. He received his Ph.D. from Harvard University in 2002 and his Sc.B. from Brown University in 1994. He has been a teacher at St. Ann's School and an Assistant Professor at the University of Connecticut. He is currently the Elihu Professor of Biostatistics at Yale University.
Most Relevant Publications (6+)

207 total publications

Potential effectiveness of long-acting injectable pre-exposure prophylaxis for HIV prevention in men who have sex with men: a modelling study

The Lancet HIV / Sep 01, 2018

Marshall, B. D. L., Goedel, W. C., King, M. R. F., Singleton, A., Durham, D. P., Chan, P. A., Townsend, J. P., & Galvani, A. P. (2018). Potential effectiveness of long-acting injectable pre-exposure prophylaxis for HIV prevention in men who have sex with men: a modelling study. The Lancet HIV, 5(9), e498–e505. https://doi.org/10.1016/s2352-3018(18)30097-3

Modelling microbial infection to address global health challenges

Nature Microbiology / Sep 20, 2019

Fitzpatrick, M. C., Bauch, C. T., Townsend, J. P., & Galvani, A. P. (2019). Modelling microbial infection to address global health challenges. Nature Microbiology, 4(10), 1612–1619. https://doi.org/10.1038/s41564-019-0565-8

The critical importance of retention in HIV prevention

The Lancet HIV / Sep 01, 2018

Golub, S. A., & Enemchukwu, C. U. (2018). The critical importance of retention in HIV prevention. The Lancet HIV, 5(9), e475–e476. https://doi.org/10.1016/s2352-3018(18)30130-9

Genomic Comparison Among Global Isolates of L. interrogans Serovars Copenhageni and Icterohaemorrhagiae Identified Natural Genetic Variation Caused by an Indel

Frontiers in Cellular and Infection Microbiology / Jun 19, 2018

Santos, L. A., Adhikarla, H., Yan, X., Wang, Z., Fouts, D. E., Vinetz, J. M., Alcantara, L. C. J., Hartskeerl, R. A., Goris, M. G. A., Picardeau, M., Reis, M. G., Townsend, J. P., Zhao, H., Ko, A. I., & Wunder, E. A. (2018). Genomic Comparison Among Global Isolates of L. interrogans Serovars Copenhageni and Icterohaemorrhagiae Identified Natural Genetic Variation Caused by an Indel. Frontiers in Cellular and Infection Microbiology, 8. https://doi.org/10.3389/fcimb.2018.00193

Lvr, a Signaling System That Controls Global Gene Regulation and Virulence in Pathogenic Leptospira

Frontiers in Cellular and Infection Microbiology / Feb 23, 2018

Adhikarla, H., Wunder, E. A., Mechaly, A. E., Mehta, S., Wang, Z., Santos, L., Bisht, V., Diggle, P., Murray, G., Adler, B., Lopez, F., Townsend, J. P., Groisman, E., Picardeau, M., Buschiazzo, A., & Ko, A. I. (2018). Lvr, a Signaling System That Controls Global Gene Regulation and Virulence in Pathogenic Leptospira. Frontiers in Cellular and Infection Microbiology, 8. https://doi.org/10.3389/fcimb.2018.00045

Cellular Superspreaders: An Epidemiological Perspective on HIV Infection inside the Body

PLoS Pathogens / May 08, 2014

Talbert-Slagle, K., Atkins, K. E., Yan, K.-K., Khurana, E., Gerstein, M., Bradley, E. H., Berg, D., Galvani, A. P., & Townsend, J. P. (2014). Cellular Superspreaders: An Epidemiological Perspective on HIV Infection inside the Body. PLoS Pathogens, 10(5), e1004092. https://doi.org/10.1371/journal.ppat.1004092

See Full Profile

Katie Barr

Warrington
8 Years Experience
Bioinformatician and developer with strong academic and commercial experience
Education

University of Leeds

Ph.D, Quantum Information / December, 2013

Leeds

University of Manchester

MSc, Mathematical logic and the theory of computation / December, 2009

Manchester

University of Bristol

BSc, Physics and Philosophy with study in Continental Europe / July, 2008

Bristol
Experience

Earlham Institute

Scientific programmer / November, 2015 — July, 2018

Genome assembly algorithm development

University of Manchester

Post doc bioinformatician in Nanomedicine group / June, 2019 — October, 2020

Wise range of bioinformatics tasks, mostly in RNASeq and Proteomics

Kromek

Associate Principal Scientist- Bioinformatics / November, 2020 — Present

Environmental metagenomics pipeline development for pathogen detection

Research Expertise (12)
Computer Science Applications
Atomic and Molecular Physics, and Optics
Bioengineering
Pharmacology (medical)
Biochemistry (medical)
And 7 more
About
Katie Barr is a bioinformatician with a strong background in computer science. She received her Ph.D in Quantum Information from the University of Leeds in 2013. She also holds an MSc in Mathematical logic and the theory of computation from the University of Manchester, and a BSc in Physics and Philosophy with study in Continental Europe from the University of Bristol. Katie has extensive experience working in the fields of bioinformatics and software development. She has worked as a scientific programmer at the Earlham Institute, a postdoctoral bioinformatician in the Nanomedicine group at the University of Manchester, and is now an Associate Principal Scientist in Bioinformatics at Kromek. Katie is passionate about using her knowledge and skills to improve the lives of others and she is dedicated to the advancement of science and technology. She believes in the power of collaboration and works to create meaningful partnerships between industry and academia.

See Full Profile

Dr. Justin Whalley, Ph.D

North Chicago, Illinois, United States of America
9 Years Experience
Assistant Professor of Bioinformatics, with experience in finding the quintessential features in large, multi-layered 'omic datasets.
Education

Université d'Évry Val-d'Essonne

Ph.D., Bioinformatics / May, 2015

Évry

University of Bristol

M.Sci., Mathematics / June, 2008

Bristol
Experience

University of Oxford

Senior Bioinformatician / 2017 — 2022

Rosalind Franklin University of Medicine and Science Chicago Medical School

Assistant Professor of Bioinformatics / 2023 — Present

CNAG

Postdoctoral Researcher / 2014 — 2017

Research Expertise (19)
Genomics
Bioinformatics
Immunity
Tensor decomposition
Cancer
And 14 more
About
Dr. Justin P. Whalley was educated in the UK (M.Sci. Mathematics, University of Bristol) and France (Ph.D. Bioinformatics, University of Évry). He moved to Spain to work as a postdoc at the National Center for Genomic Analysis (CNAG). During his time there, he ran the Quality Control working group for the Pan-Cancer Analysis of Whole Genomes project to assess the data coming in and reduce batch effects. This involved collaboration with researchers from the Broad Institute of MIT and Harvard, the German Cancer Research Center and the Wellcome Sanger Institute in the UK. He returned to the UK to work as a [Senior Bioinformatician at the University of Oxford](https://www.well.ox.ac.uk/people/jpw/). His time there coincided with the global pandemic and he was deeply involved in the COvid-19 Multi-omics Blood ATlas (COMBAT) consortium as the lead for the Integration (Tensor) working group. Dr. Whalley became a member of the [faculty of the Chicago Medical School at Rosalind Franklin University of Medicine and Science](https://www.rosalindfranklin.edu/academics/faculty/justin-p-whalley/) in January 2023.

See Full Profile

Rosani Matoso Silva, Ph.D.

11 Years Experience
Fulbrigther Humphrey Fellow 2023-2024 from Brazil
Education

Universidade Federal da Bahia

Doutora, Zootecnista / September, 2013

Salvador

Universidade Federal Rural do Rio de Janeiro

Mestrado, Zootecnia / October, 2009

Seropédica

Universidade Federal Rural do Rio de Janeiro

Graduação, Zootecnia / September, 2007

Seropédica
Experience

Instituto

Diretora-presidente / March, 2020 — Present

Universidade Federal do Recôncavo da Bahia

Pesquisadora / February, 2014 — December, 2017

Instituto Federal de Educação, Ciência e Tecnologia Baiano

Professora / February, 2013 — August, 2013

Most Relevant Research Expertise
Immunology
Other Research Expertise (7)
Zootecnia
Food Animals
Animal Science and Zoology
Safety, Risk, Reliability and Quality
Food Science
And 2 more
About
Rosani Matoso Silva is a scientific researcher and activist committed to advancing diversity and black and indigenous leadership in the fields of science and technology (S&T). Her passion and dedication to these causes led her to establish the Mancala Institute, where she serves as the director of research, spearheading innovative projects aimed at developing technological solutions to address social and racial disparities across Brazil. Rosani’s research is deeply influenced by her belief in the need for innovative methods to effectively monitor food insecurity, a critical issue affecting countless vulnerable communities. Rosani was selected for the prestigious Humphrey Fellowship program for 2023-2024, an opportunity that reflects her exceptional commitment and leadership potential. During the program, she seeks to enhance her leadership development, networking, and negotiation skills. Her goal is to build a supportive network with American organizations focused on achieving food security and sovereignty for vulnerable communities, thus expanding the impact of her work and contributing to the creation of a more just and inclusive future. Rosani Matoso Silva is a driving force in the fight for inclusion and social justice in the fields of science and technology, with an unwavering dedication to creating a world where diversity is not only recognized but valued and promoted.
Most Relevant Publications (1+)

16 total publications

Anaphylaxis to lipid transfer protein from sunflower seeds

Allergy / Sep 07, 2010

Yagami, A. (2010). Anaphylaxis to lipid transfer protein from sunflower seeds. Allergy, 65(10), 1340–1341. Portico. https://doi.org/10.1111/j.1398-9995.2010.02337.x

See Full Profile

Lindsay Webb, PhD

9 Years Experience
Immunologist and cancer biologist passionate about driving innovative research to improve patient health
Education

University of Cincinnati

BS, Cell and Molecular Biology / May, 2014

Cincinnati, Ohio, United States of America

The Ohio State University

Ph.D., Biomedical Sciences/ Immunology / December, 2018

Columbus, Ohio, United States of America
Experience

Dynamic Cell Therapies

Principal Scientist / May, 2023 — Present

TCR2 Therapeutics

Senior Scientist / May, 2021 — May, 2023

EMD Serono

Scientist / June, 2019 — May, 2021

Most Relevant Research Expertise
Immunology
Other Research Expertise (6)
Cancer Research
Immunology and Allergy
Molecular Medicine
Pharmacology
Oncology
And 1 more
About
Immunologist with expertise in T cell biology and molecular mechanisms of inflammation and anti-tumor immunity. Expert in drug development of biologics and cell therapies from early discovery to IND-enabling studies for oncology and autoimmune indications.
Most Relevant Publications (7+)

11 total publications

203 A membrane-tethered IL-15/IL-15 receptor fusion protein enhances the persistence and efficacy of CD70-targeted TRuC-T cells

Journal for ImmunoTherapy of Cancer / Nov 01, 2021

Ding, J., Webb, L., Patterson, T., Fleury, M., Zieba, A., Horton, H., Hofmeister, R., Gutierrez, D., & Tighe, R. (2021). 203 A membrane-tethered IL-15/IL-15 receptor fusion protein enhances the persistence and efficacy of CD70-targeted TRuC-T cells. Journal for ImmunoTherapy of Cancer, 9(Suppl 2), A214–A214. https://doi.org/10.1136/jitc-2021-sitc2021.203

173 Expression of a membrane-tethered IL-15/IL-15 receptor fusion protein enhances the persistence of MSLN-targeted TRuC-T cells

Journal for ImmunoTherapy of Cancer / Nov 01, 2021

Fleury, M., McCarthy, D., Horton, H., Anderson, C., Watt, A., Zieba, A., Webb, L., Ding, J., Tighe, R., Hofmeister, R., & Gutierrez, D. (2021). 173 Expression of a membrane-tethered IL-15/IL-15 receptor fusion protein enhances the persistence of MSLN-targeted TRuC-T cells. Journal for ImmunoTherapy of Cancer, 9(Suppl 2), A185–A185. https://doi.org/10.1136/jitc-2021-sitc2021.173

M9657 Is a Bispecific Tumor-Targeted Anti-CD137 Agonist That Induces MSLN-Dependent Antitumor Immunity without Liver Inflammation

Cancer Immunology Research / Dec 13, 2023

Xu, C., Zhou, X., Webb, L., Yalavarthi, S., Zheng, W., Saha, S., Schweickhardt, R., Soloviev, M., Jenkins, M. H., Brandstetter, S., Belousova, N., Alimzhanov, M., Rabinovich, B., Deshpande, A. M., Brewis, N., & Helming, L. (2023). M9657 Is a Bispecific Tumor-Targeted Anti-CD137 Agonist That Induces MSLN-Dependent Antitumor Immunity without Liver Inflammation. Cancer Immunology Research, 12(2), 195–213. https://doi.org/10.1158/2326-6066.cir-23-0243

Abstract P077: Composition of CD4 T cell subsets and impact on tumor growth control across mouse syngeneic tumor models

Cancer Immunology Research / Jan 01, 2022

Xu, C., Webb, L., Yalavarthi, S., Bourin, C., & Moisan, J. (2022). Abstract P077: Composition of CD4 T cell subsets and impact on tumor growth control across mouse syngeneic tumor models. Cancer Immunology Research, 10(1_Supplement), P077–P077. https://doi.org/10.1158/2326-6074.tumimm21-p077

757 M9657, a novel tumor-targeted conditional anti-CD137 agonist displays MSLN-dependent anti-tumor immunity

Journal for ImmunoTherapy of Cancer / Nov 01, 2021

Xu, C., Rabinovich, B., Deshpande, A., Zhou, X., Pipp, F. C., Schweickhardt, R., Webb, L., Yalavarthi, S., Bourin, C., Ghatak, P., Safi, B., Wollerton, F., Brewis, N., Munoz-Olaya, J., Belousova, N., Alimzhanov, M., Hubensack, M., Halle, J.-P., Blaukat, A., & Moisan, J. (2021). 757 M9657, a novel tumor-targeted conditional anti-CD137 agonist displays MSLN-dependent anti-tumor immunity. Journal for ImmunoTherapy of Cancer, 9(Suppl 2), A792–A792. https://doi.org/10.1136/jitc-2021-sitc2021.757

NF-κB/mTOR/MYC Axis Drives PRMT5 Protein Induction After T Cell Activation via Transcriptional and Non-transcriptional Mechanisms

Frontiers in Immunology / Mar 19, 2019

Webb, L. M., Narvaez Miranda, J., Amici, S. A., Sengupta, S., Nagy, G., & Guerau-de-Arellano, M. (2019). NF-κB/mTOR/MYC Axis Drives PRMT5 Protein Induction After T Cell Activation via Transcriptional and Non-transcriptional Mechanisms. Frontiers in Immunology, 10. https://doi.org/10.3389/fimmu.2019.00524

PRMT5-Selective Inhibitors Suppress Inflammatory T Cell Responses and Experimental Autoimmune Encephalomyelitis

The Journal of Immunology / Feb 15, 2017

Webb, L. M., Amici, S. A., Jablonski, K. A., Savardekar, H., Panfil, A. R., Li, L., Zhou, W., Peine, K., Karkhanis, V., Bachelder, E. M., Ainslie, K. M., Green, P. L., Li, C., Baiocchi, R. A., & Guerau-de-Arellano, M. (2017). PRMT5-Selective Inhibitors Suppress Inflammatory T Cell Responses and Experimental Autoimmune Encephalomyelitis. The Journal of Immunology, 198(4), 1439–1451. https://doi.org/10.4049/jimmunol.1601702

See Full Profile

Roberto M. Alers Velazquez, Ph.D.

15 Years Experience
Scientific Editor and Virology Specialist Advancing Research Through Strategic Writing and Collaboration
Education

University of Toledo

PhD, College of Natural Sciences and Mathmatics / November, 2020

Toledo, Ohio, United States of America

University of Puerto Rico

BS, College of Natural Sciences / June, 2014

Aguadilla

University of Toledo

PhD in Molecular BiologyVirology / 2020

Experience

Case Western Reserve University

Senior Scientific Editor / February, 2025 — Present

Senior Scientific Editor / February, 2025 — July

Provide editorial support to enhance clarity impact and competitiveness of grant proposals and research manuscripts. Mentor faculty fellows and researchers in strategic scientific writing. Lead writing workshops and NIH-style mock study sections to strengthen research communication skills. Collaborate across disciplines to align research narratives with institutional and sponsor priorities.

Dartmouth College Geisel School of Medicine

Postdoctoral Research Fellow / January, 2021 — February, 2025

Ohio State University

post baccalaureate / June, 2014 — June, 2015

Most Relevant Research Expertise
Immunology
Other Research Expertise (12)
Virology
Clinical and Translational Sciences
Molecular Biology
Cancer Biology
Neuroscience
And 7 more
About
I’m a scientific editor, medical writer, and virologist with expertise in transforming complex research into clear, compelling, and impactful communication. My work focuses on enhancing the clarity, accuracy, and persuasiveness of scientific documents, including grant proposals, manuscripts, and technical reports. With a foundation in molecular biology, neuroscience, and immunology, I bring both scientific rigor and editorial precision to every project I undertake. I’m passionate about helping researchers, clinicians, and organizations communicate their science effectively, bridging the gap between discovery and understanding.

See Full Profile

Giuliana Noratto

15 Years Experience
Food Scientist PhD and Registered Dietician - Texas A&M University
Education

Texas A&M University

Texas A&M University System

Ph.D., Department of Food Science and Technology

College Station

Universidad Nacional Agraria La Molina

M.Sc., Food Science and Technology

Lima
Experience

Texas A&M AgriLife

Senior Associate Research Scientist / August, 2016 — Present

Washington State

Assistant Professor - Head of Food Science lab / 2012 — 2016

Research focus is on the role of nutrition in the prevention or progress of obesity-related chronic diseases. We investigate food bioactive compounds with the main goal of uncovering the molecular mechanisms by which diet derived compounds interact with the genome (effect on gene and protein expression and biomarkers) to shift the onset or outcome of disease. Research projects are centered around: - Milk and dairy-derived bioactive compounds - Plant food botanicals

Texas A&M University

Research Scientist / 2008 — 2012

In charge of projects dealing with effects of natural plant extracts to prevent or cure cancer, diabetes, and cardiovascular complications; all these having in common to be the result of inflammation and obesity.

Research Expertise (29)
Food Science
Nutrition
Human Health
Analytical Chemistry
Nutrition and Dietetics
And 24 more
About
Dr. Giuliana Noratto is a senior associate research scientist at Texas A&M AgriLife. She received her Ph.D. in food science and technology from Texas A&M University System, and her M.Sc. in food science and technology from Universidad Nacional Agraria La Molina. She also holds a B.S. in food science and technology from Universidad Nacional Agraria La Molina. Dr. Noratto’s research interests include food safety and quality, sensory science, and food processing.

See Full Profile

Adrienne Lucas

17 Years Experience
Professsor and Department Chair of Economics, University of Delaware | Research Associate, NBER
Education

Brown University

Ph.D., Economics / 2006

Providence, Rhode Island, United States of America

Wesleyan University

BA, Economics / 1998

Middletown, Connecticut, United States of America
Experience

University of Delaware

Professor of Economics / 2011 — Present

Wellesley College

Assistant Professor of Economics / 2006 — 2013

(reappointed 2009, leave of absence 2011 – 2013)

Most Relevant Research Expertise
Immunology
Other Research Expertise (14)
Development/Education/Health Economist
Public Administration
Sociology and Political Science
Economics and Econometrics
Development
And 9 more
About
Adrienne Lucas is a professor of economics in the Alfred Lerner College of Business and Economics at the University of Delaware, a research associate of the National Bureau of Economic Research (NBER), a faculty affiliate of the Abdul Latif Jameel Poverty Action Lab (J-PAL), non-resident fellow at the Center for Global Development (CGD) and a research network member of Innovations for Poverty Action (IPA). She is a development economist specializing in the economics of education and disease. Her current research focuses on the importance of information in school choice decisions, using existing school system personnel and resources to increase student learning, and external validity across contexts. Lucas has published research on malaria, free primary education, HIV/AIDS, secondary school choice, the return to school quality, teacher incentives and improving early primary school literacy. Prior to joining the University of Delaware, she was an assistant professor of economics at Wellesley College. She received her Ph.D. and A.M. in economics from Brown University and her B.A. in economics from Wesleyan University. Watch Professor Lucas explain her work on the [intergenerational effects of HIV](https://www.youtube.com/watch?v=EBN9zwltOYQ), [improving student learning in existing schooling systems](https://vimeo.com/444330814) and the importance of [school leaders](https://www.youtube.com/watch?v=bSZNzRoS-Ms).
Most Relevant Publications (1+)

24 total publications

Gender Bias in Assessments of Teacher Performance

AEA Papers and Proceedings / May 01, 2021

Beg, S., Fitzpatrick, A., & Lucas, A. M. (2021). Gender Bias in Assessments of Teacher Performance. AEA Papers and Proceedings, 111, 190–195. https://doi.org/10.1257/pandp.20211126

See Full Profile

Tensie Whelan

23 Years Experience
Director, Center for Sustainable Business - NYU Stern School of Business
Education

Harvard University

OPM, Business School

Cambridge, Massachusetts, United States of America

American University

MA International Communication, School of International Service

Washington, District of Columbia, United States of America

New York University

BA Political Science, College of Arts and Sciences

New York, New York, United States of America
Experience

New York University Stern School of Business

Director, Clinical Professor / November, 2015 — Present

Rainforest Alliance

President / 2000 — 2015

Most Relevant Research Expertise
Immunology
Other Research Expertise (19)
sustainability
Health, Toxicology and Mutagenesis
Management, Monitoring, Policy and Law
Nature and Landscape Conservation
Pollution
And 14 more
About
Tensie Whelan is the Director of the NYU Stern Center for Sustainable Business, where she is bringing her 25 years of experience working on local, national and international sustainability issues to engage businesses in proactive and innovative mainstreaming of sustainability. Tensie has been recognized by Ethisphere as one of the 100 Most Influential People in Business Ethics and was a Citi Fellow in Leadership and Ethics at NYU Stern. Her research interests include ESG investing and sustainable business.
Most Relevant Publications (1+)

35 total publications

Investigación en acción: cómo impulsar la contribución de la universidad en la competitividad de las organizaciones

Harvard Deusto Business Research / Dec 27, 2013

Alfaro Tanco, J. A., & Avella Camarero, L. (2013). Investigación en acción: cómo impulsar la contribución de la universidad en la competitividad de las organizaciones. Harvard Deusto Business Research, 2(2), 89–101. https://doi.org/10.3926/hdbr.33

See Full Profile

Example Immunology projects

How can companies collaborate more effectively with researchers, experts, and thought leaders to make progress on Immunology?

Development of Novel Immunotherapies

An Immunology expert can collaborate with a pharmaceutical company to develop novel immunotherapies for the treatment of cancer and autoimmune diseases. Their expertise in understanding the immune system and its response to diseases can help in identifying new targets and designing effective therapies.

Drug Discovery and Development

Companies can collaborate with Immunology researchers to discover and develop new drugs. These experts can provide insights into disease mechanisms, identify potential drug targets, and evaluate the efficacy and safety of drug candidates through preclinical and clinical trials.

Biomarker Identification

Immunology experts can assist companies in identifying biomarkers that can be used for disease diagnosis, prognosis, and monitoring. These biomarkers can help in early detection, personalized treatment approaches, and assessing treatment response.

Vaccine Development

Collaborating with Immunology researchers can accelerate the development of vaccines. Their knowledge of immune responses to pathogens can aid in the design and optimization of vaccines, ensuring their effectiveness and safety.

Personalized Medicine

Immunology experts can contribute to the field of personalized medicine by understanding individual variations in immune responses. This knowledge can help in tailoring treatment approaches based on a patient's immune profile, leading to improved therapeutic outcomes.